Predicting the probability of successful efficacy of a dissociated agonist of the glucocorticoid receptor from dose–response analysis-Reference-Cited by-同舟云学术

Predicting the probability of successful efficacy of a dissociated agonist of the glucocorticoid receptor from dose–response analysis

Published:2016-05-13 Issue:3 Volume:43 Page:325-341
ISSN:1567-567X
Container-title:Journal of Pharmacokinetics and Pharmacodynamics
language:en
Short-container-title:J Pharmacokinet Pharmacodyn

Author:

Conrado Daniela J.,Krishnaswami Sriram,Shoji Satoshi,Kolluri Sheela,Hey-Hadavi Judith,McCabe Dorothy,Rojo Ricardo,Tammara Brinda K.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s10928-016-9475-z.pdf

Reference25 articles.

1. Feldmann M, Brennan FM, Maini RN (1996) Rheumatoid arthritis. Cell 85(3):307–310

2. Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. Lancet 376(9746):1094–1108. doi: 10.1016/S0140-6736(10)60826-4

3. Centers for disease control and prevention. Rheumatoid arthritis. http://www.cdc.gov/arthritis/basics/rheumatoid.htm . Accessed Feb 2015

4. Smolen JS, Aletaha D (2015) Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges. Nat Rev Rheumatol. doi: 10.1038/nrrheum.2015.8

5. Buttgereit F (2011) Do the treatment with glucocorticoids and/or the disease itself drive the impairment in glucose metabolism in patients with rheumatoid arthritis? Ann Rheum Dis 70(11):1881–1883. doi: 10.1136/annrheumdis-2011-200388

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. State-of-the-art glucocorticoid-targeted drug therapies for the treatment of rheumatoid arthritis;Expert Opinion on Pharmacotherapy;2022-03-22

2. The Effect of Pituitary Gland Disorders on Glucose Metabolism: From Pathophysiology to Management;Hormone and Metabolic Research;2020-10-12

3. Glucocorticoids in rheumatoid arthritis: the silent companion in the therapeutic strategy;Expert Review of Clinical Pharmacology;2020-06-02

4. Glucose metabolism in Cushing's syndrome;Current Opinion in Endocrinology, Diabetes & Obesity;2020-06

5. Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs;Clinical Pharmacology & Therapeutics;2019-12-05